Telephone sharing button Contact Us linkedin sharing button LinkedIn mailbox sharing button
arrow_left sharing button
arrow_right sharing button

Protein Subunit Vaccines Overview

Protein Subunit Vaccines Overview

With extensive capabilities and GMP manufacturing capacity for protein subunit vaccines, WuXi Vaccines offers accelerated end-to-end services from initial cell line development to drug substance (DS), drug product (DP) GMP production and commercial fill finish.


Our GMP facilities, equipped with BSL-1/BSL-2 capability, cover both microbial and mammalian-based manufacturing platforms. We have a world-class quality system and global manufacturing footprint of more than 300K liters in total bioreactor scale, supporting fed-batch and perfusion cell culture processes.


Speed to patients with the highest product quality and safety is core for our success in combating disease including global pandemics. Our state-of-the-art high throughput process development, broad range of analytical toolboxes, highly coordinated CMC development, and deep expertise in developing/manufacturing enable our clients to succeed with both speed and flexibility.


Our broad experience and capacity provide excellence in one-stop shop service spanning early development, late-stage process characterization/validation as well as commercialization.



You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?